| Literature DB >> 34126772 |
Elodie Ramond1,2, Anne Jamet1,2, Xiongqi Ding1,2, Daniel Euphrasie1,2, Clémence Bouvier1,2, Louison Lallemant3,4, Xiangyan He1,2, Laurence Arbibe1,2, Mathieu Coureuil1,2, Alain Charbit1,2.
Abstract
Antibiotic-resistant Staphylococcus aureus strains constitute a major public health concern worldwide and are responsible for both health care- and community-associated infections. Here, we establish a robust and easy-to-implement model of oral S. aureus infection using Drosophila melanogaster larvae that allowed us to follow the fate of S. aureus at the whole-organism level as well as the host immune responses. Our study demonstrates that S. aureus infection triggers H2O2 production by the host via the Duox enzyme, thereby promoting antimicrobial peptide production through activation of the Toll pathway. Staphylococcal catalase mediates H2O2 neutralization, which not only promotes S. aureus survival but also minimizes the host antimicrobial response, hence reducing bacterial clearance in vivo. We show that while catalase expression is regulated in vitro by the accessory gene regulatory system (Agr) and the general stress response regulator sigma B (SigB), it no longer depends on these two master regulators in vivo. Finally, we confirm the versatility of this model by demonstrating the colonization and host stimulation capabilities of S. aureus strains belonging to different sequence types (CC8 and CC5) as well as of two other bacterial pathogens, Salmonella enterica serovar Typhimurium and Shigella flexneri. Thus, the Drosophila larva can be a general model to follow in vivo the innate host immune responses triggered during infection by human pathogens. IMPORTANCE The pathogenicity of methicillin-resistant S. aureus (MRSA) strains relies on their ability to produce a wide variety of tightly regulated virulence factors. Current in vivo models to analyze host-pathogen interactions are limited and difficult to manipulate. Here, we have established a robust and reliable model of oral S. aureus infection using Drosophila melanogaster larvae. We show that S. aureus stimulates host immunity through the production of reactive oxygen species (ROS) and antimicrobial peptide (AMP) and that ROS potentialize AMP gene expression. S. aureus catalase plays a key role in this complex environment and acts in vivo independently from SigB and Agr control. We propose that fly larvae can provide a general model for studying the colonization capabilities of human pathogens.Entities:
Keywords: Drosophila melanogaster; Duox; Staphylococcus aureus; catalase; gastrointestinal infection; intestinal infection; virulence
Mesh:
Substances:
Year: 2021 PMID: 34126772 PMCID: PMC8262968 DOI: 10.1128/mBio.00276-21
Source DB: PubMed Journal: mBio Impact factor: 7.867
FIG 1The D. melanogaster larva, a model to study S. aureus USA300 virulence. (A) Mid-L3 larvae were placed in a microcentrifuge tube with 100 μl of crushed banana and 100 μl of bacteria for 30 min. Then larvae were briefly washed with 30% ethanol and transferred to a petri dish with fresh fly medium until further processing. (B) Survival of w D. melanogaster larvae following 30 min of oral infection with wild-type S aureus USA300 at the indicated infectious doses. Animals were checked 24 h after infection. Data are means ± SEM (n = 3) with 20 animals/point. One-way ANOVA and multiple-comparison tests were performed between infected animals and BHI agar-treated (noninfected) animals (*, P < 0.05; ***, P < 0.001). (C) Survival of w D. melanogaster larvae upon 30 min of oral infection with 10 × 108 S aureus USA300 WT bacteria and the nonpathogenic entomopathogen Micrococcus luteus. Animals were monitored at 0, 6, 12, 18, and 24 h after infection. Seventy animals from 3 independent experiments were used. The Kaplan-Meier test was applied to the whole group (***, P < 0.001). NI, noninfected larvae. (D) w D. melanogaster larvae were orally infected for 30 min with 1 × 108 and 10 × 108 chloramphenicol-resistant S aureus USA300 WT bacteria (carrying the pRN11 plasmid)/larva. Bacterial counts (CFU) in the gut were determined at 0.5, 6, 12, 18, and 24 h p.i. in live larvae. Tissues were homogenized in DPBS, serially diluted, and plated on BHI agar supplemented with chloramphenicol (10 μg · ml−1). Data are means ± SEM (n = 3). One-way ANOVA and then multiple-comparison tests were performed between 1 × 108 and 10 × 108 bacteria-infected larvae groups (**, P < 0.01). (E) Representative images of guts from noninfected larvae and larvae infected with mCherry-S aureus USA300 WT (carrying pRN11 plasmid) for 6 h (6 h p.i.). Animals were dissected and stained with Alexa Fluor 488 phalloidin (green) and DAPI (blue) (n = 2, 10 guts/experiment, for each condition). Scale bar, 0.5 mm. AM, anterior midgut; MM, middle midgut; PM, posterior midgut. (F) Representative Lightsheet microscope images (20×/NA 0.1 objective) from the posterior part (ventral view) of a larva infected with mCherry-S. aureus USA300 WT at 6 h p.i. F1, F2, and F3 correspond, respectively, to a frontal plane (ventral view), transversal planes (reflecting the line’s disposition in F1), and the sagittal plane (extended view). Scale bar, 100 μm. (The experiment was performed on 5 animals on 5 different inclusions).
FIG 2ROS quenching in vivo is a key mechanism for successful colonization. (A) w mid-L3 larvae were fed for 30 min with 10 × 108 live or heat-killed (HK) S. aureus USA300 WT bacteria/larva. A quantitative real-time PCR analysis of Duox transcripts was done with total RNA extracts from guts (15 animals, n = 3) recovered at 2 h p.i. Bar graph data are relative to RP49. Data are means ± SEM (n = 3). One-way ANOVA and then multiple-comparison tests between infected groups and noninfected (NI) larvae were applied (*, P < 0.05; **, P < 0.01). (B) w mid-L3 larvae were fed for 30 min with 10 × 108 S aureus USA300 WT bacteria/larva. Generation of intestinal H2O2 was measured with the H2DCFDA dye (10 μM) on noninfected samples and at 2 h p.i. Data are means ± SEM (n = 4). The Mann-Whitney test was applied (*, P < 0.05). A.U., arbitrary units. (C) Representative live imaging of posterior midguts from noninfected larvae (NI) and orally infected larvae (2 h p.i.; mCherry-S. aureus USA300 WT, red). Intestines were dissected, treated with H2DCFDA (10 μM, green) for 15 min, and imaged with an epifluorescence microscope. TL, transmitted light. White arrowheads indicate Malpighian tubules. Scale bar, 10 μm. (n = 3, 10 guts/experiment, for each condition.) (D) w D. melanogaster larvae were orally infected for 30 min at 10 × 108 bacteria/larva with chloramphenicol-resistant S aureus USA300 WT or the ΔkatA, ΔsodA, ΔsodM, ΔgpxA1, or ΔgpxA2 (carrying the pRN11 plasmid) strain. Bacterial counts (CFU) were determined at 0 6 h p.i. After homogenization and serial dilution, samples were plated on BHI agar supplemented with chloramphenicol (10 μg · ml−1). Data are means ± SEM (n = 3). One-way ANOVA and then multiple-comparison tests between mutant-infected groups and the WT-infected group were applied (*, P < 0.05). (E) Survival of w D. melanogaster larvae following 30 min of oral infection with S. aureus USA300 WT ΔkatA ΔkatA-cp-katA with 10 × 108 bacteria/larva. The experiment was monitored until 24 h after infection. Sixty-two animals were pooled from 3 independent experiments. The Kaplan-Meier test was applied for the whole group (***, P < 0.001). (F) w D. melanogaster larvae were orally infected for 30 min at 10 × 108 bacteria/larva with chloramphenicol-resistant S aureus USA300 WT or the ΔkatA mutant (carrying the pRN11 plasmid). Bacterial counts (CFU) were determined at 0.5, 2, 4, and 6 h p.i. After homogenization and serial dilution, samples were plated on BHI agar supplemented with chloramphenicol (10 μg · ml−1). Data are means ± SEM (n = 3). One-way ANOVA and then multiple-comparison tests were performed between WT and ΔkatA-infected larval groups (**, P < 0.01; ***, P < 0.001). (G) w mid-L3 larvae were fed for 30 min with chloramphenicol-resistant S. aureus USA300 WT or the ΔkatA mutant at the infectious dose of 10 × 108 bacteria/larva. The intestinal ROS titer was measured at 0.5, 2, and 6 h p.i. After dissection, intestines were homogenized in 400 μl DPBS and treated with H2DCFDA (10 μM) for 30 min. Fluorescence was measured at 490 nm. Data are means ± SEM (n = 3). One-way ANOVA and then multiple-comparison tests were performed between WT- and ΔkatA-infected larval groups (*, P < 0.05; **, P < 0.01). (H) w D. melanogaster mid-L3 larvae were orally infected for 30 min with chloramphenicol-resistant S. aureus USA300 WT or the ΔkatA mutant (carrying the pRN11 plasmid) at the infectious dose of 10 × 108 bacteria/larva. Then animals were transferred to fresh fly medium supplemented, or not, with NAC (1 mM). Bacterial counts (CFU) were determined at 0.5, 2, and 6 h p.i. After homogenization and serial dilution, samples were plated on BHI agar supplemented with chloramphenicol (10 μg · ml−1). Data are means ± SEM (n = 4). One-way ANOVA and then multiple-comparison tests were performed (*, P < 0.05; ***, P < 0.001). (I) NP3084-GAL4 > w and NP3084-GAL4 > Duox RNAi larvae were orally infected for 30 min with chloramphenicol-resistant S. aureus USA300 WT or the ΔkatA mutant (carrying the pRN11 plasmid) at the infectious dose of 10 × 108 bacteria/larva. Bacterial counts (CFU) were determined at 0.5, 2, and 6 h p.i. After homogenization and serial dilution, samples were plated on BHI agar supplemented with chloramphenicol (10 μg · ml−1). Data are means ± SEM (n = 4). One-way ANOVA and then multiple-comparison tests were performed (*, P < 0.05; **, P < 0.01; ***, P < 0.001).
FIG 3S. aureus USA300 modulates the antimicrobial response by neutralizing intestinal ROS. (A) yw and yw;;spz mid-L3 larvae were fed for 30 min with the infectious doses of 1 × 108 and 10 × 108 bacteria/larva. Quantitative real-time PCR analysis of Drosomycin transcripts was done with total RNA extracts from guts recovered at 6 h p.i. Bar graph data are presented in relation to RP49. Data are means ± SEM (n = 3). One-way ANOVA and then multiple-comparison tests were performed between the “yw NI Gut” condition” and all other conditions (NS, nonsignificant; ***, P < 0.001). (B) w mid-L3 larvae were orally infected for 30 min with S aureus USA300 WT or the ΔkatA or ΔkatA-cp-katA strain at the infectious dose of 10 × 108 bacteria/larva. At 6 h p.i., guts were dissected for quantitative real-time PCR analysis of Drosomycin transcripts. Data were normalized to the corresponding RP49 levels. Data are means ± SEM (n = 3). One-way ANOVA and then multiple-comparison tests were performed (*, P < 0.05). (C) w mid-L3 larvae were fed for 2 h with fly medium supplemented with stabilized H2O2 (0.5%). Guts were dissected for quantitative real-time PCR analysis of Drosomycin transcripts. Transcripts levels were normalized to the corresponding RP49 levels. Data are means ± SEM (n = 3). The Mann-Whitney test was applied to compare the nontreated (NT) group and H2O2-treated group (*, P < 0.05). (D) w mid-L3 larvae were orally infected for 30 min with S aureus USA300 WT or S. aureus USA300 ΔkatA at the infectious dose of 10 × 108 bacteria/larva. Then animals were transferred to fresh fly medium supplemented, or not, with NAC (1 mM). At 6 h p.i., guts were dissected for quantitative real-time PCR analysis of Drosomycin transcripts. Data were normalized to the corresponding RP49 levels. Results were compared to those for noninfected larvae transferred to supplemented NAC medium (NI+NAC) or not (NI). Data are means ± SEM (n = 4). One-way ANOVA and then multiple-comparison tests were performed (*, P < 0.05; **, P < 0.01).
FIG 4katA expression is differently mediated in vitro and in vivo. (A) Survival of w D. melanogaster larvae following 30 min of oral infection (10 × 108 bacteria/larva) with S. aureus USA300 WT or the ΔsigB, ΔsigB-cp-sigB, ΔagrC, or ΔagrC-cp-agrC strain against noninfected animals (NI). The experiment was monitored until 24 h after infection. At least 60 animals were pooled under each condition from 3 independent experiments. The Kaplan-Meier test was used to compare the whole group (***, P < 0.001). (B) w D. melanogaster larvae were orally infected for 30 min at 10 × 108 bacteria/larva with chloramphenicol-resistant S aureus USA300 WT (carrying the pRN11 plasmid, plated on BHI agar with chloramphenicol) or the ΔsigB, ΔsigB-cp-sigB, ΔagrC, or ΔagrC-cp-agrC strain (plated on BHI agar with erythromycin). Bacterial counts (CFU) were determined at 6 h p.i. Data are means ± SEM (n = 3). One-way ANOVA and then multiple-comparison tests were performed (*, P < 0.05). (C, D) Exponentially grown S. aureus WT (C), the ΔsigB mutant (D, left panel), or the ΔagrC mutant (D, right panel) were incubated for 30 min in DPBS with or without (NT) H2O2 15 mM. Quantitative real-time PCR analyses of katA (C), sigB (D, left panel), or agrC (D, right panel) transcripts were performed. Transcripts levels were normalized to the corresponding gyrB levels. Data are means ± SEM (n = 3). One-way ANOVA and then multiple-comparison tests were performed (*, P < 0.05; **, P < 0.01; ***, P < 0.001). (E) NP3084-GAL4 > w and NP3084-GAL4 > Duox RNAi larvae were orally infected for 30 min with S. aureus USA300 WT (10 × 108 bacteria/larva). At 2 h p.i., quantitative real-time PCR analyses of the katA strain were performed. Transcripts levels were normalized to the corresponding gyrB levels. Data are means ± SEM (n = 3). The Mann-Whitney test was applied to compare groups (**, P < 0.01). (F, G) w D. melanogaster larvae were orally infected for 30 min with WT S. aureus or the ΔsigB, ΔsigB-cp-sigB, ΔagrC, or ΔagrC-cp-agrC strain (10 × 108 bacteria/larva). At 6 h p.i., quantitative real-time PCR analyses of katA (F), sigB (G, left), or agrC (G, right) were performed. Transcripts levels were normalized to the corresponding gyrB levels and expressed relative to WT results for panel F. Data are means ± SEM (n = 3). One-way ANOVA and then multiple-comparison tests were performed, and results were compared to those for the WT-infected group (*, P < 0.05; **, P < 0.01).
FIG 5Model of S. aureus USA300 H2O2 quenching in Drosophila intestine. (A) In the intestine, S. aureus exerts a cell wall and secretome-mediated activation of Duox transcription, thus leading to H2O2 production in the gut lumen (1). This activates bacterial kata transcription (2), which will quench hydrogen peroxide molecules in order to both counteract bacterial clearing from ROS and limit Drosomycin gene transcription, whose expression is positively regulated by H2O2 (3). (B) In vitro, under H2O2 treatment, S. aureus katA expression is activated by Agr and to a lesser extent by SigB, which undergoes negative transcriptional regulation by H2O2. Additional regulators positively influence katA. In vivo, we observed that SigB and Agr repress katA expression, thus highlighting the complex regulatory network that influences katA expression.
Strains and plasmids used in this study
| Strain or plasmid | Relevant characteristics | Source or reference(s) |
|---|---|---|
| Strains | ||
| | MRSA, USA300-LAC (ST8), Eryr | BEI Resources (NR46070) |
| | This work | |
| | MRSA USA300 JE2 isolate (plasmid-cured derivative of strain USA300-LAC, ST8), Eryr, transposon insertion in the | BEI Resources (NE1366) |
| | This work | |
| | Complemented strain JE2 Δ | This work |
| | MRSA USA300 JE2 isolate (plasmid-cured derivative of strain USA300-LAC, ST8), Eryr, transposon insertion in the | BEI Resources (NE1224) |
| | This work | |
| | MRSA USA300 JE2 isolate (plasmid-cured derivative of strain USA300-LAC, ST8), Eryr, transposon insertion in the | BEI Resources (NE1932) |
| | This work | |
| | MRSA, USA300 JE2 isolate (plasmid-cured derivative of strain USA300-LAC, ST8), Eryr, transposon insertion in the | BEI Resources (NE1730) |
| | This work | |
| | MRSA, USA300 JE2 isolate (plasmid-cured derivative of strain USA300-LAC, ST8), Eryr, transposon insertion in the | BEI Resources (NE1366) |
| | This work | |
| | MRSA, USA300 JE2 isolate (plasmid-cured derivative of strain USA300-LAC, ST8), Eryr, transposon insertion in | BEI Resources (NE1366) |
| | This work | |
| | Complemented strain | This work |
| | MRSA, USA300 JE2 isolate (plasmid-cured derivative of strain USA300-LAC, ST8), Eryr, transposon insertion in the | BEI Resources (NE1366) |
| | This work | |
| | Complemented strain | This work |
| | Clinical isolate MSSA ST1, PVL+, isolated from blood culture |
|
| | MSSA ST5, PVL–, isolated from blood culture | This work |
| | MSSA ST30, PVL–, isolated from a skin infection | This work |
| | Gift from D. Ferrandon laboratory | |
| |
| |
| | ||
| Plasmids | ||
| pRN11 |
| |
| pCN57 | Plasmid containing the |
|
| pCN57-cp- | pCN57 plasmid containing the | This work |
| pCN57-cp- | pCN57 plasmid containing the | This work |
| pCN57-cp- | pCN57 plasmid containing the | This work |
D. melanogaster lines
| Source | Reference or identifier | |
|---|---|---|
| D. Ferrandon | ||
| D. Ferrandon |
| |
| D. Ferrandon |
| |
|
| W. J. Lee | DGRC (113094) |
|
| W. J. Lee |
|
Oligonucleotides used in this study
| Oligonucleotide | Sequence |
|---|---|
| GAC GCT TCA AGG GAC AGT ATC TG | |
| AAA CGC GGT TCT GCA TGA G | |
| CGT GAG AAC CTT TTC CAA TAT GAT | |
| TCC CAG GAC CAC CAG CAT | |
| GCT GCG CAA TCG CTT CTA CT | |
| TGG TGG AGT GGG CTT CAT G | |
| CAA CAC CAC GGG ATG TCG AA | |
| CGA CCA TCA GCT GCT CCA TT | |
| CTG GGA TTT CTG GAC GGG TC | |
| TGA GAA CCG AAC CCA TGC AT | |
| AGG TGG TAC GCA TGA AGA CG | |
| TTC AAC CAC TGT ACG TGC GA | |
| TGC GTT AAG TGT TGA TCA TTC CA | |
| TGG TCA TCT TGT TGC CCC AT | |
| ACC CTA TCA TTC GCG TTG CA | |
| CGT GGT ATA TCA TCA GCG CA | |
| atc gga ggg ttt att ctg caC AGT AGC TAC AAA TAG ACC | |
| atc cat aca aTT ATT TTT CAA AGT TTT CGT ATG TTT C | |
| tga aaa ata aTT GTA TGG ATT AGT CGA GC | |
| ggg atc ctc tag agt cga ccT CAG AAG AAC TCG TCA AG | |
|
| gtt ctt ctg aGG CGC GCC TAT TCT AAA TG |
|
| tta cc aat gtT CTT AAA TTA ATT AGT TAA CGA ATT CGA GC |
| taa ttt aag aAC ATT GGT AAC ATC GCA G | |
| atc cat aca aAT CCT TAT GGC TAG TTG TTA ATA ATT TC | |
| cca taa gga tTT GTA TGG ATT AGT CGA GC | |
| tag gcg cgc cTC AGA AGA ACT CGT CAA G | |
| aat ttg ttt aTT GTA TGG ATT AGT CGA GC | |
| taa aaa gtc tTG CAG AAT AAA CCC TCC G | |
| tta ttc tgc aAG ACT TTT TAC GCG AAG G | |
| atc cat aca aTA AAC AAA TTC TAT TGA TGT GC |
Lowercase and uppercase letters indicate the pairings at each sequence.